13Indexed trials
mesh condition
Tauopathies
Intelligence
Tauopathies intelligence: 13 indexed trials, 3 recruiting studies, 12 sponsors across 29 countries.
3Recruiting
12Sponsors
29Countries
Leading sponsors
Tammie L. S. Benzinger, MD, PhD21 recruiting
Eisai Co., Ltd.10 recruiting
Eisai Limited10 recruiting
Elizabeth K Rhodus10 recruiting
Hoffmann-La Roche10 recruiting
Inmune Bio, Inc.10 recruiting
Affiris AG10 recruiting
MODAG GmbH10 recruiting
MapLight Therapeutics11 recruiting
Novartis Pharmaceuticals11 recruiting
Sinotau Pharmaceutical Group10 recruiting
Jae Seung Kim10 recruiting
Geographic activity
United States5trials
France5trials
Germany3trials
Canada3trials
South Korea3trials
Poland3trials
Spain3trials
Czechia3trials
United Kingdom3trials
Slovakia2trials
China2trials
Finland2trials
Leading interventions
E20202trials
F 18 T8072trials
Drug: [18F]florbetaben1trials
Fluvoxamine 100 mg QD for 5 days1trials
Harmony at HOME (H@H)1trials
ML-007C-MA1trials
Matching placebo1trials
NIO7521trials
XPro15951trials
[18F]PI-26201trials
AFFITOPE® AD021trials
anle138b (TEV-56286)1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.